Follow The Filings

UTI Universal Technical Inst Inc.

Consumer Discretionary, filed as UNIVERSAL TECHNICAL INST INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2

  • 2 Owners
  • Max 3.4%
  • $62M
  • 1 new 1 add

In 2026 Q2 Spencer Waxman opened a position in Universal Technical Inst, and First Eagle Investment Management added.

Who owns this now

Largest portfolio weights among holders, up to 3.4% (Spencer Waxman, Shannon River Fund Management). Not free-float ownership.

  1. Spencer Waxman New 3.4%
  2. First Eagle Investment Manage... Add 0.04%

Who owns UTI

Sorted by value, long equity only, as of 2026 Q2.

History
Spencer Waxman, Shannon River Fund Management 3.4% New 3.4% 890,113 $38M History
First Eagle Investment Management 0.04%, was 0.03% Add +20.8% 570,235 $24M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by UTI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All UTI insider trades
  • $31.1M bought by 2 insiders
  • $135M sold by 11 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Robert Thomas Devincenzi Director
    Buy
    $20K 1,000 shares at $19.68 +0.7% to stake
    Traded Sep 28 Filed Sep 30
    ↗
  2. Robert Thomas Devincenzi Director
    Buy
    $20K 1,000 shares at $19.83 +0.7% to stake
    Traded Sep 21 Filed Sep 23
    ↗
  3. Robert Thomas Devincenzi Director
    Buy
    $22K 1,000 shares at $21.80 +0.7% to stake
    Traded Aug 27 Filed Aug 31
    ↗
  4. Robert Thomas Devincenzi Director
    Buy
    $22K 1,000 shares at $21.77 +0.7% to stake
    Traded Aug 25 Filed Aug 27
    ↗
  5. Robert Thomas Devincenzi Director
    Buy
    $26K 1,000 shares at $25.95 +0.7% to stake
    Traded Aug 12 Filed Aug 14
    ↗
  6. Robert Thomas Devincenzi Director
    Buy
    $226K 8,000 shares at $28.21 +5.7% to stake
    Traded Aug 10 Filed Aug 12
    ↗
  7. Jerome Alan Grant CEO
    Sale
    $3.9M 94,500 shares at $41.40 22% of stake
    Traded Jun 29 Filed Jun 30
    ↗
  8. Kevin Prehn Concorde Division President
    Sale
    $182K 4,545 shares at $40.00 14% of stake
    Traded Jun 22 Filed Jun 24
    ↗
  9. Coliseum Capital Management, LLC Director, +4 joint filers
    Sale
    $124M 3,000,000 shares at $41.40 76% of stake
    Traded Jun 8 Filed Jun 10
    ↗
  10. Christine Kline Senior Vice President and CAO
    Sale
    $155K 3,500 shares at $44.42 7.5% of stake
    Traded Jun 5 Filed Jun 8
    ↗
  11. Linda J Srere Director
    Sale
    $549K 15,000 shares at $36.59 11% of stake
    Traded May 11 Filed May 13
    ↗
  12. Christopher E. Kevane EVP and Chief Legal Officer
    Sale
    $888K 23,654 shares at $37.55 22% of stake
    Traded Mar 27 Filed Mar 31
    ↗
  13. George W. Brochick Director
    Sale
    $183K 5,000 shares at $36.59 15% of stake
    Traded Mar 17 Filed Mar 18
    ↗
  14. Shannon Lei Okinaka Director
    Sale
    $347K 10,000 shares at $34.74 34% of stake
    Traded Mar 6 Filed Mar 9
    ↗
  15. Todd A Hitchcock COO
    Sale
    $616K 16,500 shares at $37.33 14% of stake
    Traded Mar 4 Filed Mar 6
    ↗

Also filed in the last 12 months, not counted as buying or selling: 36 share withholdings for taxes, 27 stock grants, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 1.01,2.03,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
8-K 5.05 Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $607.41M $732.69M $835.62M
Net income $12.32M $42M $63.02M
Net margin * 2.0% 5.7% 7.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $204.98M $221.95M $246.63M
Total non-current assets * $535.7M $522.62M $579.51M
Total assets $740.68M $744.58M $826.14M
Total current liabilities $184.7M $204.96M $229.67M
Total non-current liabilities * $330.02M $279.38M $268.36M
Total equity $225.97M $260.23M $328.11M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $49.15M $85.9M $97.33M
Cash from investing -$44.07M -$24M -$87.88M
Cash from financing $81.85M -$51.34M -$42.79M
Net change in cash $86.93M $10.55M -$33.34M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.